SCHEMBL25812124

SCHEMBL25812124

Cc1ccc(-c2noc(-c3cnc4ccc(Cl)cn34)n2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.57
CASP3 P42574 2/20 0.47
NPC1 O15118 9/20 0.45
RAB9A P51151 8/20 0.45
NFKB1 P19838 5/20 0.45
NFKB2 Q00653 5/20 0.45
RELA Q04206 5/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 7/20 0.43
L3MBTL1 Q9Y468 4/20 0.43
TP53 P04637 4/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPK1 P28482 2/20 0.43
LMNA P02545 1/20 0.43
FLT3 P36888 2/20 0.43
MAPT P10636 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
POLB P06746 2/20 0.42
EIF2AK4 Q9P2K8 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23977681 0.88 AHR (0.47) NR1H4CASP3NPC1RAB9AMEN1
SCHEMBL25813764 0.83 NPC1 (0.45) NR1H4CASP3NPC1RAB9ANFKB1
SCHEMBL23977684 0.82 NR1H4 (0.38) NR1H4CASP3NPC1RAB9ASMN1; SMN2
SCHEMBL23977685 0.80 TSHR (0.55) NPC1MEN1KMT2ASMN1; SMN2TP53
SCHEMBL23977683 0.80 SMN1; SMN2 (0.47) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL12998313 0.78 PIK3CA (0.48) FLT3POLBEIF2AK4
SCHEMBL312801 0.77 FLT3 (0.44) NR1H4CASP3NPC1RAB9ASMN1; SMN2
SCHEMBL17100937 0.70 NR1H4 (0.68) NR1H4CASP3NPC1RAB9ANFKB1
SCHEMBL25322090 0.69 PIK3CA (0.38) NR1H4NPC1RAB9ANFKB1NFKB2
SCHEMBL312431 0.69 FLT3 (0.43) FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219893-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease US GOV VETERANS AFFAIRS (US) 2023-07-13 US disclosed
US-11643394-B2 Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11643394-B2 Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease KIF15, KLF5, KLF10 NR1H4 1765/4885CASP3 2141/4885NPC1 834/4885
US-20230219893-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease KIF15, KLF5, KLF10 NR1H4 1765/4885CASP3 2141/4885NPC1 834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.